APO Research
Talk to an analyst

APO RESEARCH · REPORT

Formulation Development Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Formulation Development Service Market Analysis and Forecast 2026-2032

12 April 2026180 pages

Choose your research edition.

Industry ResearchFormulation Development Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Formulation Development Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Formulation Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Formulation Development Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Formulation Development Service Market Analysis and Forecast 2026-2032180 pages · $4,950 USD

Market perspective

The global Formulation Development Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Formulation Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Formulation Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Formulation Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Formulation Development Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Formulation Development Service include Lonza, Recipharm, Catalent, Thermo Fisher Scientific, Ardena, Intertek, Quay Pharma, Avivia and Piramal Pharma Solutions, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Formulation Development Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Formulation Development Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Formulation Development Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Formulation Development Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Formulation Development Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Formulation Development Service revenue, projected growth trends, production technology, application and end-user industry.

Formulation Development Service Segment by Company

Lonza

Recipharm

Catalent

Thermo Fisher Scientific

Ardena

Intertek

Quay Pharma

Avivia

Piramal Pharma Solutions

Syngene

Kemwell Biopharma

Evonik Industries AG

SGS SA

Coriolis Pharma

Doppel Farmaceutici Srl

Nuvisan

Quotient Sciences

Medpharm

Curia

Formulation Development Service Segment by Type

Sterile Dosage Forms

Non-sterile Dosage Forms

Formulation Development Service Segment by Application

Pharmaceutical Industry

Health Care Products Industry

Others

Formulation Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Formulation Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Formulation Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Formulation Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Formulation Development Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Formulation Development Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Formulation Development Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Formulation Development Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sterile Dosage Forms Major Player Table 3. Non-sterile Dosage Forms Major Player Table 4. Global Formulation Development Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Industry Major Player Table 6. Health Care Products Industry Major Player Table 7. Others Major Player Table 8. Formulation Development Service Industry Trends Table 9. Formulation Development Service Industry Drivers Table 10. Formulation Development Service Industry Opportunities and Challenges Table 11. Formulation Development Service Industry Restraints Table 12. Global Formulation Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Formulation Development Service Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Formulation Development Service Market Share by Region (2021-2026) Table 15. Global Formulation Development Service Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Formulation Development Service Market Share by Region (2027-2032) Table 17. Global Formulation Development Service Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Formulation Development Service Revenue Market Share by Players (2021-2026) Table 19. Global Formulation Development Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Formulation Development Service Key Players Headquarters & Area Served Table 21. Global Formulation Development Service Players, Product Type & Application Table 22. Global Formulation Development Service Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Formulation Development Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Formulation Development Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Formulation Development Service Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Formulation Development Service Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Formulation Development Service Revenue Market Share by Type (2021-2026) Table 29. Global Formulation Development Service Revenue Market Share by Type (2027-2032) Table 30. Global Formulation Development Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Formulation Development Service Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Formulation Development Service Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Formulation Development Service Revenue Market Share by Application (2021-2026) Table 34. Global Formulation Development Service Revenue Market Share by Application (2027-2032) Table 35. Lonza Company Information Table 36. Lonza Business Overview Table 37. Lonza Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Lonza Formulation Development Service Product Portfolio Table 39. Lonza Recent Development Table 40. Recipharm Company Information Table 41. Recipharm Business Overview Table 42. Recipharm Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Recipharm Formulation Development Service Product Portfolio Table 44. Recipharm Recent Development Table 45. Catalent Company Information Table 46. Catalent Business Overview Table 47. Catalent Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Catalent Formulation Development Service Product Portfolio Table 49. Catalent Recent Development Table 50. Thermo Fisher Scientific Company Information Table 51. Thermo Fisher Scientific Business Overview Table 52. Thermo Fisher Scientific Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Thermo Fisher Scientific Formulation Development Service Product Portfolio Table 54. Thermo Fisher Scientific Recent Development Table 55. Ardena Company Information Table 56. Ardena Business Overview Table 57. Ardena Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Ardena Formulation Development Service Product Portfolio Table 59. Ardena Recent Development Table 60. Intertek Company Information Table 61. Intertek Business Overview Table 62. Intertek Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Intertek Formulation Development Service Product Portfolio Table 64. Intertek Recent Development Table 65. Quay Pharma Company Information Table 66. Quay Pharma Business Overview Table 67. Quay Pharma Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Quay Pharma Formulation Development Service Product Portfolio Table 69. Quay Pharma Recent Development Table 70. Avivia Company Information Table 71. Avivia Business Overview Table 72. Avivia Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Avivia Formulation Development Service Product Portfolio Table 74. Avivia Recent Development Table 75. Piramal Pharma Solutions Company Information Table 76. Piramal Pharma Solutions Business Overview Table 77. Piramal Pharma Solutions Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Piramal Pharma Solutions Formulation Development Service Product Portfolio Table 79. Piramal Pharma Solutions Recent Development Table 80. Syngene Company Information Table 81. Syngene Business Overview Table 82. Syngene Formulation Development Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Syngene Formulation Development Service Product Portfolio Table 84. Syngene Recent Development Table 85. Kemwell Biopharma Company Information Table 86. Kemwell Biopharma Business Overview Table 87. Kemwell Biopharma Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Kemwell Biopharma Formulation Development Service Product Portfolio Table 89. Kemwell Biopharma Recent Development Table 90. Evonik Industries AG Company Information Table 91. Evonik Industries AG Business Overview Table 92. Evonik Industries AG Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Evonik Industries AG Formulation Development Service Product Portfolio Table 94. Evonik Industries AG Recent Development Table 95. SGS SA Company Information Table 96. SGS SA Business Overview Table 97. SGS SA Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. SGS SA Formulation Development Service Product Portfolio Table 99. SGS SA Recent Development Table 100. Coriolis Pharma Company Information Table 101. Coriolis Pharma Business Overview Table 102. Coriolis Pharma Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Coriolis Pharma Formulation Development Service Product Portfolio Table 104. Coriolis Pharma Recent Development Table 105. Doppel Farmaceutici Srl Company Information Table 106. Doppel Farmaceutici Srl Business Overview Table 107. Doppel Farmaceutici Srl Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Doppel Farmaceutici Srl Formulation Development Service Product Portfolio Table 109. Doppel Farmaceutici Srl Recent Development Table 110. Nuvisan Company Information Table 111. Nuvisan Business Overview Table 112. Nuvisan Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Nuvisan Formulation Development Service Product Portfolio Table 114. Nuvisan Recent Development Table 115. Quotient Sciences Company Information Table 116. Quotient Sciences Business Overview Table 117. Quotient Sciences Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Quotient Sciences Formulation Development Service Product Portfolio Table 119. Quotient Sciences Recent Development Table 120. Medpharm Company Information Table 121. Medpharm Business Overview Table 122. Medpharm Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Medpharm Formulation Development Service Product Portfolio Table 124. Medpharm Recent Development Table 125. Curia Company Information Table 126. Curia Business Overview Table 127. Curia Formulation Development Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Curia Formulation Development Service Product Portfolio Table 129. Curia Recent Development Table 130. North America Formulation Development Service Revenue by Type (2021-2026) & (US$ Million) Table 131. North America Formulation Development Service Revenue by Type (2027-2032) & (US$ Million) Table 132. North America Formulation Development Service Revenue by Application (2021-2026) & (US$ Million) Table 133. North America Formulation Development Service Revenue by Application (2027-2032) & (US$ Million) Table 134. North America Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Formulation Development Service Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Formulation Development Service Revenue by Country (US$ Million) & (2027-2032) Table 137. Europe Formulation Development Service Revenue by Type (2021-2026) & (US$ Million) Table 138. Europe Formulation Development Service Revenue by Type (2027-2032) & (US$ Million) Table 139. Europe Formulation Development Service Revenue by Application (2021-2026) & (US$ Million) Table 140. Europe Formulation Development Service Revenue by Application (2027-2032) & (US$ Million) Table 141. Europe Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe Formulation Development Service Revenue by Country (2021-2026) & (US$ Million) Table 143. Europe Formulation Development Service Revenue by Country (US$ Million) & (2027-2032) Table 144. China Formulation Development Service Revenue by Type (2021-2026) & (US$ Million) Table 145. China Formulation Development Service Revenue by Type (2027-2032) & (US$ Million) Table 146. China Formulation Development Service Revenue by Application (2021-2026) & (US$ Million) Table 147. China Formulation Development Service Revenue by Application (2027-2032) & (US$ Million) Table 148. Asia Formulation Development Service Revenue by Type (2021-2026) & (US$ Million) Table 149. Asia Formulation Development Service Revenue by Type (2027-2032) & (US$ Million) Table 150. Asia Formulation Development Service Revenue by Application (2021-2026) & (US$ Million) Table 151. Asia Formulation Development Service Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Formulation Development Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Asia Formulation Development Service Revenue by Region (US$ Million) & (2021-2026) Table 154. Asia Formulation Development Service Revenue by Region (US$ Million) & (2027-2032) Table 155. SAMEA Formulation Development Service Revenue by Type (2021-2026) & (US$ Million) Table 156. SAMEA Formulation Development Service Revenue by Type (2027-2032) & (US$ Million) Table 157. SAMEA Formulation Development Service Revenue by Application (2021-2026) & (US$ Million) Table 158. SAMEA Formulation Development Service Revenue by Application (2027-2032) & (US$ Million) Table 159. SAMEA Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. SAMEA Formulation Development Service Revenue by Country (2021-2026) & (US$ Million) Table 161. SAMEA Formulation Development Service Revenue by Country (US$ Million) & (2027-2032) Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Formulation Development Service Image Figure 2. Global Formulation Development Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Formulation Development Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sterile Dosage Forms Image Figure 5. Non-sterile Dosage Forms Image Figure 6. Global Formulation Development Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Formulation Development Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Industry Image Figure 9. Health Care Products Industry Image Figure 10. Others Image Figure 11. Global Formulation Development Service Market Size (US$ Million) & (2021-2032) Figure 12. Global Formulation Development Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Formulation Development Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Formulation Development Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Formulation Development Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Formulation Development Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Formulation Development Service Revenue Market Share by Type (2021-2032) Figure 19. Global Formulation Development Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Formulation Development Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Formulation Development Service Revenue Market Share by Application (2021-2032) Figure 22. North America Formulation Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Formulation Development Service Revenue Share by Type (2021-2032) Figure 24. North America Formulation Development Service Revenue Share by Application (2021-2032) Figure 25. North America Formulation Development Service Revenue Share by Country (2021-2032) Figure 26. United States Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Formulation Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Formulation Development Service Revenue Share by Type (2021-2032) Figure 31. Europe Formulation Development Service Revenue Share by Application (2021-2032) Figure 32. Europe Formulation Development Service Revenue Share by Country (2021-2032) Figure 33. Germany Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Formulation Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Formulation Development Service Revenue Share by Type (2021-2032) Figure 43. China Formulation Development Service Revenue Share by Application (2021-2032) Figure 44. Asia Formulation Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Formulation Development Service Revenue Share by Type (2021-2032) Figure 46. Asia Formulation Development Service Revenue Share by Application (2021-2032) Figure 47. Asia Formulation Development Service Revenue Share by Region (2021-2032) Figure 48. Japan Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Formulation Development Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Formulation Development Service Revenue Share by Type (2021-2032) Figure 56. SAMEA Formulation Development Service Revenue Share by Application (2021-2032) Figure 57. SAMEA Formulation Development Service Revenue Share by Country (2021-2032) Figure 58. Brazil Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Formulation Development Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Sterile Dosage Forms
  • Non-sterile Dosage Forms
Applications
  • Pharmaceutical Industry
  • Health Care Products Industry
  • Others
Companies covered
  • Lonza
  • Recipharm
  • Catalent
  • Thermo Fisher Scientific
  • Ardena
  • Intertek
  • Quay Pharma
  • Avivia
  • Piramal Pharma Solutions
  • Syngene
  • Kemwell Biopharma
  • Evonik Industries AG
  • SGS SA
  • Coriolis Pharma
  • Doppel Farmaceutici Srl
  • Nuvisan
  • Quotient Sciences
  • Medpharm
  • Curia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Formulation Development Service Market by Type
  3. 1.2.1 Global Formulation Development Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sterile Dosage Forms
  5. 1.2.3 Non-sterile Dosage Forms
  6. 1.3 Formulation Development Service Market by Application
  7. 1.3.1 Global Formulation Development Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical Industry
  9. 1.3.3 Health Care Products Industry
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Formulation Development Service Market Dynamics
  1. 2.1 Formulation Development Service Industry Trends
  2. 2.2 Formulation Development Service Industry Drivers
  3. 2.3 Formulation Development Service Industry Opportunities and Challenges
  4. 2.4 Formulation Development Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Formulation Development Service Market Perspective (2021-2032)
  2. 3.2 Global Formulation Development Service Growth Trends by Region
  3. 3.2.1 Global Formulation Development Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Formulation Development Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Formulation Development Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Formulation Development Service Revenue by Players
  2. 4.1.1 Global Formulation Development Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Formulation Development Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Formulation Development Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Formulation Development Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Formulation Development Service Key Players Headquarters & Area Served
  7. 4.4 Global Formulation Development Service Players, Product Type & Application
  8. 4.5 Global Formulation Development Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Formulation Development Service Market CR5 and HHI
  11. 4.6.3 2025 Formulation Development Service Tier 1, Tier 2, and Tier 3
5 Formulation Development Service Market Size by Type
  1. 5.1 Global Formulation Development Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Formulation Development Service Revenue by Type (2021-2032)
  3. 5.3 Global Formulation Development Service Revenue Market Share by Type (2021-2032)
6 Formulation Development Service Market Size by Application
  1. 6.1 Global Formulation Development Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Formulation Development Service Revenue by Application (2021-2032)
  3. 6.3 Global Formulation Development Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lonza
  2. 7.1.1 Lonza Company Information
  3. 7.1.2 Lonza Business Overview
  4. 7.1.3 Lonza Formulation Development Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lonza Formulation Development Service Product Portfolio
  6. 7.1.5 Lonza Recent Developments
  7. 7.2 Recipharm
  8. 7.2.1 Recipharm Company Information
  9. 7.2.2 Recipharm Business Overview
  10. 7.2.3 Recipharm Formulation Development Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Recipharm Formulation Development Service Product Portfolio
  12. 7.2.5 Recipharm Recent Developments
  13. 7.3 Catalent
  14. 7.3.1 Catalent Company Information
  15. 7.3.2 Catalent Business Overview
  16. 7.3.3 Catalent Formulation Development Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Catalent Formulation Development Service Product Portfolio
  18. 7.3.5 Catalent Recent Developments
  19. 7.4 Thermo Fisher Scientific
  20. 7.4.1 Thermo Fisher Scientific Company Information
  21. 7.4.2 Thermo Fisher Scientific Business Overview
  22. 7.4.3 Thermo Fisher Scientific Formulation Development Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific Formulation Development Service Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific Recent Developments
  25. 7.5 Ardena
  26. 7.5.1 Ardena Company Information
  27. 7.5.2 Ardena Business Overview
  28. 7.5.3 Ardena Formulation Development Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Ardena Formulation Development Service Product Portfolio
  30. 7.5.5 Ardena Recent Developments
  31. 7.6 Intertek
  32. 7.6.1 Intertek Company Information
  33. 7.6.2 Intertek Business Overview
  34. 7.6.3 Intertek Formulation Development Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Intertek Formulation Development Service Product Portfolio
  36. 7.6.5 Intertek Recent Developments
  37. 7.7 Quay Pharma
  38. 7.7.1 Quay Pharma Company Information
  39. 7.7.2 Quay Pharma Business Overview
  40. 7.7.3 Quay Pharma Formulation Development Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Quay Pharma Formulation Development Service Product Portfolio
  42. 7.7.5 Quay Pharma Recent Developments
  43. 7.8 Avivia
  44. 7.8.1 Avivia Company Information
  45. 7.8.2 Avivia Business Overview
  46. 7.8.3 Avivia Formulation Development Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Avivia Formulation Development Service Product Portfolio
  48. 7.8.5 Avivia Recent Developments
  49. 7.9 Piramal Pharma Solutions
  50. 7.9.1 Piramal Pharma Solutions Company Information
  51. 7.9.2 Piramal Pharma Solutions Business Overview
  52. 7.9.3 Piramal Pharma Solutions Formulation Development Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Piramal Pharma Solutions Formulation Development Service Product Portfolio
  54. 7.9.5 Piramal Pharma Solutions Recent Developments
  55. 7.10 Syngene
  56. 7.10.1 Syngene Company Information
  57. 7.10.2 Syngene Business Overview
  58. 7.10.3 Syngene Formulation Development Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Syngene Formulation Development Service Product Portfolio
  60. 7.10.5 Syngene Recent Developments
  61. 7.11 Kemwell Biopharma
  62. 7.11.1 Kemwell Biopharma Company Information
  63. 7.11.2 Kemwell Biopharma Business Overview
  64. 7.11.3 Kemwell Biopharma Formulation Development Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Kemwell Biopharma Formulation Development Service Product Portfolio
  66. 7.11.5 Kemwell Biopharma Recent Developments
  67. 7.12 Evonik Industries AG
  68. 7.12.1 Evonik Industries AG Company Information
  69. 7.12.2 Evonik Industries AG Business Overview
  70. 7.12.3 Evonik Industries AG Formulation Development Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Evonik Industries AG Formulation Development Service Product Portfolio
  72. 7.12.5 Evonik Industries AG Recent Developments
  73. 7.13 SGS SA
  74. 7.13.1 SGS SA Company Information
  75. 7.13.2 SGS SA Business Overview
  76. 7.13.3 SGS SA Formulation Development Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 SGS SA Formulation Development Service Product Portfolio
  78. 7.13.5 SGS SA Recent Developments
  79. 7.14 Coriolis Pharma
  80. 7.14.1 Coriolis Pharma Company Information
  81. 7.14.2 Coriolis Pharma Business Overview
  82. 7.14.3 Coriolis Pharma Formulation Development Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Coriolis Pharma Formulation Development Service Product Portfolio
  84. 7.14.5 Coriolis Pharma Recent Developments
  85. 7.15 Doppel Farmaceutici Srl
  86. 7.15.1 Doppel Farmaceutici Srl Company Information
  87. 7.15.2 Doppel Farmaceutici Srl Business Overview
  88. 7.15.3 Doppel Farmaceutici Srl Formulation Development Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Doppel Farmaceutici Srl Formulation Development Service Product Portfolio
  90. 7.15.5 Doppel Farmaceutici Srl Recent Developments
  91. 7.16 Nuvisan
  92. 7.16.1 Nuvisan Company Information
  93. 7.16.2 Nuvisan Business Overview
  94. 7.16.3 Nuvisan Formulation Development Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Nuvisan Formulation Development Service Product Portfolio
  96. 7.16.5 Nuvisan Recent Developments
  97. 7.17 Quotient Sciences
  98. 7.17.1 Quotient Sciences Company Information
  99. 7.17.2 Quotient Sciences Business Overview
  100. 7.17.3 Quotient Sciences Formulation Development Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Quotient Sciences Formulation Development Service Product Portfolio
  102. 7.17.5 Quotient Sciences Recent Developments
  103. 7.18 Medpharm
  104. 7.18.1 Medpharm Company Information
  105. 7.18.2 Medpharm Business Overview
  106. 7.18.3 Medpharm Formulation Development Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Medpharm Formulation Development Service Product Portfolio
  108. 7.18.5 Medpharm Recent Developments
  109. 7.19 Curia
  110. 7.19.1 Curia Company Information
  111. 7.19.2 Curia Business Overview
  112. 7.19.3 Curia Formulation Development Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Curia Formulation Development Service Product Portfolio
  114. 7.19.5 Curia Recent Developments
8 North America
  1. 8.1 North America Formulation Development Service Revenue (2021-2032)
  2. 8.2 North America Formulation Development Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Formulation Development Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Formulation Development Service Revenue by Type (2027-2032)
  5. 8.3 North America Formulation Development Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Formulation Development Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Formulation Development Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Formulation Development Service Revenue by Application (2027-2032)
  9. 8.5 North America Formulation Development Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Formulation Development Service Revenue by Country
  11. 8.6.1 North America Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Formulation Development Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Formulation Development Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Formulation Development Service Revenue (2021-2032)
  2. 9.2 Europe Formulation Development Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Formulation Development Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Formulation Development Service Revenue by Type (2027-2032)
  5. 9.3 Europe Formulation Development Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Formulation Development Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Formulation Development Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Formulation Development Service Revenue by Application (2027-2032)
  9. 9.5 Europe Formulation Development Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Formulation Development Service Revenue by Country
  11. 9.6.1 Europe Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Formulation Development Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Formulation Development Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Formulation Development Service Revenue (2021-2032)
  2. 10.2 China Formulation Development Service Revenue by Type (2021-2032)
  3. 10.2.1 China Formulation Development Service Revenue by Type (2021-2026)
  4. 10.2.2 China Formulation Development Service Revenue by Type (2027-2032)
  5. 10.3 China Formulation Development Service Revenue Share by Type (2021-2032)
  6. 10.4 China Formulation Development Service Revenue by Application (2021-2032)
  7. 10.4.1 China Formulation Development Service Revenue by Application (2021-2026)
  8. 10.4.2 China Formulation Development Service Revenue by Application (2027-2032)
  9. 10.5 China Formulation Development Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Formulation Development Service Revenue (2021-2032)
  2. 11.2 Asia Formulation Development Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Formulation Development Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Formulation Development Service Revenue by Type (2027-2032)
  5. 11.3 Asia Formulation Development Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Formulation Development Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Formulation Development Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Formulation Development Service Revenue by Application (2027-2032)
  9. 11.5 Asia Formulation Development Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Formulation Development Service Revenue by Country
  11. 11.6.1 Asia Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Formulation Development Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Formulation Development Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Formulation Development Service Revenue (2021-2032)
  2. 12.2 SAMEA Formulation Development Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Formulation Development Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Formulation Development Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Formulation Development Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Formulation Development Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Formulation Development Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Formulation Development Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Formulation Development Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Formulation Development Service Revenue by Country
  11. 12.6.1 SAMEA Formulation Development Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Formulation Development Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Formulation Development Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst